EXPERT INTERVIEWS

Guy Berchem

Dr Guy Berchem (GB) is an oncologist and Director of Research at the Centre Hospitalier de Luxembourg (CHL), having also recently been appointed Associated Medical Director at the Luxembourg Institute of Health (LIH). As a “clinician scientist” with dual expertise in both research and healthcare, Dr Berchem is currently playing a crucial role in the setup of clinical studies on Covid-19 in Luxembourg, in close collaboration with the Clinical and Epidemiological Investigation Centre (CIEC) at LIH. In this short interview, he discusses his expertise and involvement in ongoing Covid-19 projects.

Dr Guy Berchem © Paul Foguenne
Rudi Balling

Prof. Rudi Balling (RB), Director of the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg, is coordinating approaches for COVID-19 statistical projections and their potential for political decision support for the healthcare system within the Research Luxembourg COVID-19 Taskforce. In this short interview, he discusses his expertise and involvement in ongoing COVID-19 projects.

Prof Rudi Balling © scienceRelations
Dirk Brenner

Prof Dirk Brenner (DB) is Deputy Head of Research & Strategy and leads the Experimental and Molecular Immunology research group at the LIH Department of Infection and Immunity. As an immunologist, his research focuses on unravelling the links between the immune system and the onset of a variety of diseases. In the context of the COVID-19 pandemic, Prof Brenner and his team are currently involved in the provision of evidence-based advice on the coronavirus to the Luxembourg government and other relevant stakeholders, as well as contributing to improving the understanding of the way the infection spreads among the Luxembourgish population. In this short interview, he discusses his expertise and involvement in ongoing COVID-19 projects.

Prof Dirk Brenner © FNR
Paul Wilmes

Prof. Paul Wilmes (PW) is Principal Investigator at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, whose research focuses on how microbial communities impact our health. In the context of the COVID-19 pandemic, he is deputy spokesperson for the COVID-19 Task Force of Research Luxembourg. As the representative of the University of Luxembourg in the Task Force, he is in charge of coordination between researchers working in the different focus areas, directing certain projects reflecting an immediate need as well as the liaison with the Ministries, hospitals and research institutions in Luxembourg. In this short interview, he discusses his expertise and involvement in ongoing COVID-19 projects.

Prof Paul Wilmes © FNR